Log In
Print this Print this

enhanced T-cell therapy targeting AFP

  Manage Alerts
Collapse Summary General Information
Company Adaptimmune Therapeutics plc
DescriptionAutologous T cells genetically modified to express T cell receptors (TCR) targeting alpha fetoprotein (AFP)
Molecular Target Alpha fetoprotein (AFP)
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPhase I
Standard IndicationLiver cancer
Indication DetailsTreat locally advanced or metastatic hepatocellular carcinoma (HCC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today